Objective Handgrip strength (HGS) is a simple, non-invasive measure associated with disability, frailty and disease activity ...

The numbers are clearly better, I'm healthier and definitely happier, so it does make sense that that has gone into the ...

The FDA approved the combination of pembrolizumab (Keytruda) and enfortumab vedotin-ejfv (Padcev) for neoadjuvant and ...

Patients with initially low- or intermediate-risk primary tumors will often have a high-risk recurrence before progressing to more advanced disease, whereas primary high-risk tumors typically show ...

The addition of atezolizumab to BCG did not yield improved EFS compared with BCG alone in patients with high-risk ...

The experimental therapy M102 slowed disease progression in preclinical experiments done in mouse and cell models of ALS, a ...